The AI Platform for Automated Evidence Review

From abstract screening to structured data extraction, GenexAI automates your entire systematic literature review pipeline — cutting timelines by up to 90% 

Register now Book a demo

Trusted by
industry leaders

How much time do you spend analyzing data before taking action?

Move from data to action 5x faster without missing any detail

GenexAI helps organizations accelerate abstract screening, full-text evaluation, and data extraction so teams can produce evidence faster and with greater consistency.


Our solutions

We acceleratie the most time-intensive parts of evidence review — from abstract screening to full-text evaluation and structured data extraction — reducing manual work from days to hours.

Clinical/Regulatory Pathway

  • State of the Art analysis
  • Systematic Literature Reviews

Our evidence review capabilities provide powerful options to automate and enhance processes such as Systematic Literature Reviews or State-of-the-art (SOTA) analysis

Sales/Marketing Pathway

  • Sales Materials
  • Value Selling

Empower your sales and marketing teams to deliver compelling, data-driven narratives to multiple stakeholders, ensuring they communicate value effectively and close deals with confidence.

Integrated Projects

Our integrated projects service offers tailored solutions; we address complex needs with personalized reports and fine-tuned strategies. We meet your specific demands, providing customized solutions for your organization.

Explore our solutions
“At GenexAI, we empower life science teams to reclaim hours lost in data analysis by delivering precise and actionable insights with unmatched speed. Our platform transforms data into decisions, enabling you to focus on what truly matters - innovation and impact.”
Ernesto M. Nogueira

Founder & CEO

Using GenexAI will benefit your company in multiple ways

Efficiency

5

faster analyses than traditional processes

cost saving

80%

reduced cost compared to traditional processes

faster market entry

15

months cut of product launch timelines

improved

Accuracy

Enhance decision-making with precise, actionable insights

improved

Flexibility

Comprehensive multi-language data analysis for global reach

improved

Compliance

stay ahead of regulatory requirements with reliable data monitoring

Apply GenexAI across multiple departments

  • Medical/Clinical Affairs

    • Accelerate clinical trial insights through rapid evidence assessment
    • Perform fast and thorough evidence reviews
    • Enhance identification of clinical benefits and claims

  • Regulatory Affairs

    • Streamline periodic data reviews and compliance reporting.
    • Speed up updating and creating (technical) documentation
    • Accelerate post market surveillance activities and tasks

  • Market Access / Health Economics

    • Extract key value messages
    • Identify clinical and economic benefits
    • Optimize pricing strategies

  • Public Policy

    • Streamline policy impact assessments
    • Automate legislative and competition monitoring
    • Enhance advocacy strategies

  • Sales Teams

    • Accelerate sales with data-driven insights
    • Automate competitive landscape analysis
    • Enhance customer segmentation and targeting

  • Strategic Marketing

    • Analyze market trends quickly
    • Enhance customer targeting
    • Optimize marketing materials

Testimonials

"We used the GenexAI platform to quickly review the literature and assess how certain hospital-acquired infections currently impact hospitalization, mortality and costs as well as long-term implications for health care systems, which provided valuable insights for our Medical Affairs team at BD.
Prof. Stefan Schraag

Director Medical Affairs at BD

"Using GenexAI for my work has been a game-changer. It significantly reduced the time spent on literature review without sacrificing quality, enabling me to focus on achieving more meaningful outcomes.
Marianne Engel

Researcher at Charité

Universitätsmedizin Berlin

"Because GenexAI has their own model with millions of carefully curated data points & vectors, their systems are far less likely to hallucinate than large general models like OpenAI or Gemini, also because GenexAI applies its self-validation process.
Michelle Greenwald

Forbes Magazine Contributor

We are committed to ethical AI practices.

We ensure our technology is not only advanced and innovative but also responsible and trustworthy.

About GenexAI